Trial Profile
Clinical Trials Insight: 700009219
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 27 Nov 2005
Price :
$35
*
At a glance
- Drugs SGS 742 (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Sponsors Lundbeck A/S
- 27 Nov 2005 New trial record.